Summit Financial’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.8M Sell
27,168
-8,788
-24% -$2.67M 0.13% 147
2026
Q1
$7.69M Buy
35,956
+4,542
+14% +$1.02M 0.1% 211
2025
Q4
$5.39M Buy
31,414
+13,335
+74% +$2.07M 0.08% 242
2025
Q3
$2.42M Buy
18,079
+10,174
+129% +$1.08M 0.04% 434
2025
Q2
$771K Buy
7,905
+863
+12% +$68.4K 0.02% 468
2025
Q1
$512K Sell
7,042
-1,123
-14% -$88.4K 0.01% 506
2024
Q4
$592K Sell
8,165
-145
-2% -$11K 0.02% 417
2024
Q3
$680K Buy
8,310
+1,560
+23% +$136K 0.03% 324
2024
Q2
$720K Buy
6,750
+4,440
+192% +$426K 0.03% 270
2024
Q1
$225K Sell
2,310
-690
-23% -$60.7K 0.01% 357
2023
Q4
$236K Buy
+3,000
New +$204K 0.02% 326
2022
Q1
Sell
-3,460
Closed -$249K 254
2021
Q4
$249K Buy
+3,460
New +$217K 0.02% 223

Other funds holding LRCX

Summit Financial's LRCX Position: Q2 2026 in Review

Summit Financial reduced its Lam Research (LRCX) stake by 24% in Q2 2026, selling an estimated $2.67M and leaving 27,168 shares worth $11.8M. The position accounts for 0.13% of the portfolio, ranked #147.

Summit Financial first reported a position in LRCX in Q4 2021 and has held it in 12 quarters since. 3,118 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Summit Financial held 27,168 shares of Lam Research worth $11.8M as of Q2 2026.
  • Summit Financial sold 8,788 Lam Research shares in Q2 2026, an estimated $2.67M.
  • Lam Research made up 0.13% of Summit Financial's portfolio in Q2 2026, its #147 holding.
  • Summit Financial first reported a position in Lam Research in Q4 2021 and has held it in 12 quarters since.
  • 3,118 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Summit Financial's 13F filing for Q2 2026, filed 12 Aug 2026.